Out of the 21 breast cancer participants, 5 were diagnosed with luminal B breast cancer, 5 had triple-negative breast cancer, 5 had HER2 enriched breast cancer, 5 had normal-like breast cancer and one was diagnosed with luminal A breast cancer. This evidence concerns the gene ERBB2 and breast cancer.